pirfenidone has been researched along with Carcinoma, Epidermoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, K; Enokida, K; Hattori, S; Hayama, N; Hirabayashi, K; Horio, Y; Ito, Y; Miyaoka, M; Niimi, K; Oguma, T; Ohshinden, K; Takahashi, F; Takahashi, G; Takahashi, M; Takiguchi, H; Takihara, T; Tanaka, J | 1 |
| Cheng, X; Han, X; Li, J; Yu, H; Yu, L; Zhang, X | 1 |
| Katayama, Y; Komada, T; Kusagawa, H; Shomura, S | 1 |
1 review(s) available for pirfenidone and Carcinoma, Epidermoid
| Article | Year |
|---|---|
[A Case Report of Checkpoint Inhibitor Pneumonitis Caused by PD-1
Antibody-Safety and Effectiveness of Pirfenidone].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Squamous Cell; Glucocorticoids; Humans; Immune Checkpoint Inhibitors; Indoles; Lung Neoplasms; Male; Nivolumab; Pneumonia; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Pyridones; Quinolines; Retrospective Studies | 2021 |
2 other study(ies) available for pirfenidone and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Cyclosporine; Humans; Idiopathic Pulmonary Fibrosis; Lung; Lung Neoplasms; Male; Pyridones; Treatment Outcome | 2021 |
[Successful resection of lung cancer with idiopathic pulmonary fibrosis treated by pirfenidone during perioperative period].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Perioperative Period; Pyridones | 2013 |